August 7, 2020

The Niche

Knoepfler lab stem cell blog

Masayo Takahashi

6 min read

When are iPS cell-based therapies ready to be tested in actual people? It’s the million or perhaps even billion dollar question of today in the stem cell field. I realize that perhaps it is also a dangerous question, politically-speaking, for me to ask in a public forum, but patient lives as well as potentially the progress of the entire iPS cell field are at stake. So someone needs to start an open discussion about this topic. People are certainly talking about it behind the …Read More

2 min read

It is always exciting when a biomedical technology as revolutionary as iPS cells is on the cusp of being used in patients for the first time. In the last few days stories have reported about how a proposed clinical trial based on iPS cells has completed several regulatory steps and is closer to starting. This is exciting, but the trial also has the potential for many risks. Just one risk stems from the fact that how cells behave in mice or other rodents or …Read More